TL8-506 (GMP)
TL8-506 (GMP) is TL8-506 produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. TL8-506 is a specific TLR8 agonist with an EC50 of 30 nM. TL8-506 has immunomodulatory effects and can be used in the study of tuberculosis and cancer immunotherapy[1][2].
Product Specifications
CAS Number
1268163-15-0
UNSPSC
12352005
Target
Bacterial; Interleukin Related; Toll-like Receptor (TLR)
Related Pathways
Anti-infection; Immunology/Inflammation
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(C1=CC2=CC=C(C3=CC=CC(C#N)=C3)C=C2N=C(N)C1)OCC
Molecular Formula
C20H17N3O2
Molecular Weight
331.37
References & Citations
[1]Jun Tang, et al. Toll-Like Receptor 8 Agonist Strengthens the Protective Efficacy of ESAT-6 Immunization to Mycobacterium tuberculosis Infection. Front Immunol. 2018 Jan 24;8:1972. |[2]He M, S, et al. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. J Immunother Cancer. 2022 Jun;10 (6) :e004268.
Shipping Conditions
Room temperature
Scientific Category
GMP Small Molecules
Clinical Information
No Development Reported
Isoform
TLR8
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A08108-2-Cy3 100 µg/Vial
Anti-RNF34 Antibody Picoband®, Cy3 Conjugate
Sign In for Pricing
View Details